The effect of COVID-19 on oncology practice in Turkey

Ismail Beypinar1

  • 1Eskisehir City Hospital, Department of Medical Oncology 71 Evler Mahallesi, Cavdarlar SK. , 26080 Odunpazarı/Eskisehir Evler Mah, Turkey.

Abstract

Insights

Turkish oncologists faced significant practice disruptions due to the COVID-19 pandemic, impacting cancer care delivery and physician motivation. Further studies are needed to address these challenges in oncology practice.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic significantly impacted global healthcare systems, including cancer care.
  • While changes in cancer treatment were assessed, the impact on physicians, particularly oncologists, remained unclear.

Purpose of the Study:

  • To evaluate the alterations in the daily practice of Turkish oncologists during the COVID-19 pandemic.
  • To understand the challenges faced by oncologists in maintaining cancer care amidst the pandemic.

Main Methods:

  • An online survey was distributed to oncologists registered with the Turkish Society of Medical Oncology.
  • Data was collected from 128 participating oncologists.

Main Results:

  • 23% of oncologists relocated facilities, leading to ~90% worse patient services.
  • 31% reported practice disturbances due to COVID-19 service duties, with 85% affected by other specialists' involvement.
  • 22% referred patients to other clinics, highlighting care fragmentation.

Conclusions:

  • Oncologists adapted to practice changes, but prolonged pandemic may decrease motivation and hinder multidisciplinary care.
  • There is a need for follow-up research to assess the long-term effects on oncology practice and patient management.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
21
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
568